MIT researchers report lipid nanoparticles that reprogram NK cells in mice to target diseased T cells
A study published Oct. 13 described an approach using lipid nanoparticles to deliver mRNA that reprograms natural killer cells in mice, with preclinical results against melanoma, T cell lymphoma and autoimmune hepatitis.




